Global Needle free Injector Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 4453775
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
The Global Needle Free Injector Market is Expected to Have a CAGR of 15% During Forecast Period 2016-2023.

FEATURED COMPANIES

  • Astrazeneca(England)
  • Crossject (France)
  • Injex Pharma Ag (Germany)
  • Merck (U.S.)
  • Mylan (U.S.)
  • Pharmajet (U.S.)
  • MORE

The key factors driving the market growth are increasing incidence of chronic diseases, rising incidence of communicable diseases due to needlestick injuries, growing demand for self-injection devices and advantages of drug delivery technology. However, the key restraining factors such as availability of alternative modes of drug delivery such as thin film drug delivery, magnetic drug delivery, self-micro emulsifying drug delivery system, acoustic targeted drug delivery etc. is expected to hinder the growth of global needle free injector market.

On the basis of geography, North America is the dominant region for global needle free injector market. This is due to the rising prevalence of chronic diseases, such as Alzheimer’s, cancer, stroke, etc. As per Center for Disease Control and Prevention, heart stroke is the third leading cause of death in United States. Furthermore, as per National Cancer Institute, in 2016, approximately 1,685,210 new cases of cancer were diagnosed in United States and around 595,690 people died from cancer. However, Europe is the fastest growing market during forecast period 2016-2023 due to the rising demand for biologics in European region.

The global needle free injector market is influenced by the presence of key market players such as Endo international PLC, Crossject, AstraZeneca, Asia Pharma Pharmaceutical ltd., etc. Product launch, joint venture, merger and acquisition are some of the crucial strategies adopted by the key market players to gain competitive advantage.

The report on global needle free injector market includes technologies, site of delivery, types of medication, usability, product, end users and applications. Segmentation of technology includes jet-based, laser-powered, spring-based and vibration-based needle free injector. The jet based needle free injector is the leading technology segment due to its several advantages, such as high accuracy and precision as compared to other technologies. On the basis of site of delivery, the market is segregated into intra dermal injectors, intramuscular injectors and subcutaneous injectors. Furthermore, report covers segmentation analysis on the basis of types of medication which include liquid-based, powder-based and projectile/depot-based needle free injectors. Liquid based needle free injector is the dominating medication segment owing to its high flexibility. Furthermore, on the basis of products, the market is segmented into fillable needle-free injectors and prefilled needle-free injectors. The end users of needle free injector are hospital and clinics, home care settings, research laboratories and others.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astrazeneca(England)
  • Crossject (France)
  • Injex Pharma Ag (Germany)
  • Merck (U.S.)
  • Mylan (U.S.)
  • Pharmajet (U.S.)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology
2. Market Overview

2.1. Global Needle Free Injector Market : Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Market Share Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Increasing Incidence of Chronic Diseases
3.1.2. Rising Incidence of Communicable Diseases Due to Needle Stick Injuries
3.1.3. Growing Demand for Self-Injection Devices
3.1.4. Advantages of Drug Delivery Technology
3.2. Market Restraints
3.2.1. Alternative Modes of Drug Delivery
3.3. Market Opportunities
3.3.1. Growing Demand for Biosimilars And Vaccination
3.3.2. Emerging Markets of Needle Free Injection
3.4. Market Challenges
3.4.1. Need to Ensure System Sterility
3.4.2. Higher Cost of Development

4. Market Segmentation
4.1. Global Needle Free Injector Market By End User
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4. Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global Hospital & Clinics Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.1.3. Key Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.2. Global Home Care Settings Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.2.3. Key Players & Key Products
4.1.5.2.4. Key Conclusions
4.1.5.3. Global Research Laboratories Market
4.1.5.3.1. Adoption Scenario & Market Determinants
4.1.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.3.3. Key Players & Key Products
4.1.5.3.4. Key Conclusions
4.1.5.4. Global Other End User Market
4.1.5.4.1. Adoption Scenario & Market Determinants
4.1.5.4.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.4.3. Key Players & Key Products
4.1.5.4.4. Key Conclusions
4.2. Global Needle Free Injector Market By Site of Delivery
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4. Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Intradermal Injectors Market
4.2.5.1.1. Adoption Scenario & Market Determinants
4.2.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.3. Key Players & Key Products
4.2.5.1.4. Key Conclusions
4.2.5.2. Global Intramuscular Injectors Market
4.2.5.2.1. Adoption Scenario & Market Determinants
4.2.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.3. Key Players & Key Products
4.2.5.2.4. Key Conclusions
4.2.5.3. Global Subcutaneous Injectors Market
4.2.5.3.1. Adoption Scenario & Market Determinants
4.2.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.3.3. Key Players & Key Products
4.2.5.3.4. Key Conclusions
4.3. Global Needle Free Injector Market By Application
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4. Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Vaccine Needle Free Delivery Market
4.3.5.1.1. Adoption Scenario & Market Determinants
4.3.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.1.3. Key Players & Key Products
4.3.5.1.4. Key Conclusions
4.3.5.2. Global Insulin Needle Free Delivery Market
4.3.5.2.1. Adoption Scenario & Market Determinants
4.3.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.2.3. Key Players & Key Products
4.3.5.2.4. Key Conclusions
4.3.5.3. Global Pain Management Needle Free Delivery Market
4.3.5.3.1. Adoption Scenario & Market Determinants
4.3.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.3.3. Key Players & Key Products
4.3.5.3.4. Key Conclusions
4.3.5.4. Global Oncology Needle Free Delivery Market
4.3.5.4.1. Adoption Scenario & Market Determinants
4.3.5.4.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.4.3. Key Players & Key Products
4.3.5.4.4. Key Conclusions
4.3.5.5. Global Others Applications Market
4.3.5.5.1. Adoption Scenario & Market Determinants
4.3.5.5.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.5.3. Key Players & Key Products
4.3.5.5.4. Key Conclusions
4.4. Global Needle Free Injector Market By Type of Medication
4.4.1. Market Definition And Scope
4.4.2. Decision Support Database & Estimation Methodology
4.4.3. Comparative Analysis Across Market Segments
4.4.4. Opportunity Matrix
4.4.5. Market Segmentation
4.4.5.1. Global Liquid-Based Needle Free Injectors Market
4.4.5.1.1. Adoption Scenario & Market Determinants
4.4.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.1.3. Key Players & Key Products
4.4.5.1.4. Key Conclusions
4.4.5.2. Global Powder-Based Needle Free Injectors Market
4.4.5.2.1. Adoption Scenario & Market Determinants
4.4.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.2.3. Key Players & Key Products
4.4.5.2.4. Key Conclusions
4.4.5.3. Global Projectile/Depot-Based Needle Free Injectors Market
4.4.5.3.1. Adoption Scenario & Market Determinants
4.4.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.3.3. Key Players & Key Products
4.4.5.3.4. Key Conclusions
4.5. Global Needle Free Injector Market By Usability
4.5.1. Market Definition And Scope
4.5.2. Decision Support Database & Estimation Methodology
4.5.3. Comparative Analysis Across Market Segments
4.5.4. Opportunity Matrix
4.5.5. Market Segmentation
4.5.5.1. Global Disposable Needle-Free Injectors Market
4.5.5.1.1. Adoption Scenario & Market Determinants
4.5.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.5.5.1.3. Key Players & Key Products
4.5.5.1.4. Key Conclusions
4.5.5.2. Global Reusable Needle-Free Injectors Market
4.5.5.2.1. Adoption Scenario & Market Determinants
4.5.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.5.5.2.3. Key Players & Key Products
4.5.5.2.4. Key Conclusions
4.6. Global Needle Free Injector Market By Product
4.6.1. Market Definition And Scope
4.6.2. Decision Support Database & Estimation Methodology
4.6.3. Comparative Analysis Across Market Segments
4.6.4. Opportunity Matrix
4.6.5. Market Segmentation
4.6.5.1. Global Fillable Needle-Free Injectors Market
4.6.5.1.1. Adoption Scenario & Market Determinants
4.6.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.6.5.1.3. Key Players & Key Products
4.6.5.1.4. Key Conclusions
4.6.5.2. Global Prefilled Needle-Free Injectors Market
4.6.5.2.1. Adoption Scenario & Market Determinants
4.6.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.6.5.2.3. Key Players & Key Products
4.6.5.2.4. Key Conclusions
4.7. Global Needle Free Injector Market By Technology
4.7.1. Market Definition And Scope
4.7.2. Decision Support Database & Estimation Methodology
4.7.3. Comparative Analysis Across Market Segments
4.7.4. Opportunity Matrix
4.7.5. Market Segmentation
4.7.5.1. Global Jet-Based Needle-Free Injectors Market
4.7.5.1.1. Adoption Scenario & Market Determinants
4.7.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.7.5.1.3. Key Players & Key Products
4.7.5.1.4. Key Conclusions
4.7.5.2. Global Laser-Powered Needle-Free Injectors Market
4.7.5.2.1. Adoption Scenario & Market Determinants
4.7.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.7.5.2.3. Key Players & Key Products
4.7.5.2.4. Key Conclusions
4.7.5.3. Global Spring-Based Needle-Free Injectors Market
4.7.5.3.1. Adoption Scenario & Market Determinants
4.7.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.7.5.3.3. Key Players & Key Products
4.7.5.3.4. Key Conclusions
4.7.5.4. Global Vibration-Based Needle-Free Injectors Market
4.7.5.4.1. Adoption Scenario & Market Determinants
4.7.5.4.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.7.5.4.3. Key Players & Key Products
4.7.5.4.4. Key Conclusions

5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Mergers And Acquisition
5.1.2. List of Joint Ventures
5.1.3. List of Product Launches
5.1.4. List of Partnerships

6. Geographic Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4. Global Needle Free Injector Market By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Key Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Key Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Key Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Key Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Key Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Key Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Key Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Key Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Key Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Key Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Key Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Key Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Key Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Key Players & Key Products
6.4.4.2.2.3. Key Conclusions

7. Company Profiles
7.1. Asia Pharma Pharmaceutical Ltd (Malaysia)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Strategic Initiatives
7.1.4. Scot Analysis
7.1.5. Strategic Analysis
7.2. Astrazeneca(England)
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Strategic Initiatives
7.2.4. Scot Analysis
7.2.5. Strategic Analysis
7.3. Bioject Medical Technologies (U.S.)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Strategic Initiatives
7.3.4. Scot Analysis
7.3.5. Strategic Analysis
7.4. Crossject (France)
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Strategic Initiatives
7.4.4. Scot Analysis
7.4.5. Strategic Analysis
7.5. Endo International Plc (U.S.)
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Strategic Initiatives
7.5.4. Scot Analysis
7.5.5. Strategic Analysis
7.6. Envision Pharma Group (England)
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Strategic Initiatives
7.6.4. Scot Analysis
7.6.5. Strategic Analysis
7.7. Injex Pharma Ag (Germany)
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Strategic Initiatives
7.7.4. Scot Analysis
7.7.5. Strategic Analysis
7.8. Inovio Pharmaceuticals Inc. (U.S.)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Strategic Initiatives
7.8.4. Scot Analysis
7.8.5. Strategic Analysis
7.9. Medical International Technology Inc. (Canada)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Strategic Initiatives
7.9.4. Scot Analysis
7.9.5. Strategic Analysis
7.10. Merck (U.S.)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Strategic Initiatives
7.10.4. Scot Analysis
7.10.5. Strategic Analysis
7.11. Mylan (U.S.)
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Strategic Initiatives
7.11.4. Scot Analysis
7.11.5. Strategic Analysis
7.12. National Medical Products Inc. (U.S.)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Strategic Initiatives
7.12.4. Scot Analysis
7.12.5. Strategic Analysis
7.13. Pharmajet (U.S.)
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Strategic Initiatives
7.13.4. Scot Analysis
7.13.5. Strategic Analysis
7.14. Valeritas Inc. (U.S.)
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Strategic Initiatives
7.14.4. Scot Analysis
7.14.5. Strategic Analysis
7.15. Zogenix (U.S.)
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Strategic Initiatives
7.15.4. Scot Analysis
7.15.5. Strategic Analysis

List of Tables
1. Global Needle Free Injector Market By End User 2014 -2023 ($ Million)
2. Global Hospitals And Clinics Market By Geography 2014 -2023 ($ Million)
3. Global Home Care Settings Market By Geography 2014-2022, ($ Millions)
4. Global Research Laboratories Market By Geography 2014 -2023 ($ Million)
5. Global Pharmaceutical And Biotechnological Companies Market By Geography 2014 -2023 ($ Million)
6. Global Other End Users Market By Geography 2014 -2023 ($ Million)
7. Global Needle Free Injector Market By Usability 2014 -2023 ($ Million)
8. Global Disposable Needle-Free Injectors Market Geography 2014 -2023 ($ Million)
9. Global Reusable Needle-Free Injectors Market By Geography 2014 -2023 ($ Million)
10. Global Needle Free Injector Market By Application 2014 -2023 ($ Million)
11. Global Vaccine Needle Free Delivery Market By Geography 2014 -2023 ($ Million)
12. Global Insulin Needle Free Delivery Market By Geography2014 -2023 ($ Million)
13. Global Pain Management Needle Free Delivery Market By Geography 2014 -2023 ($ Million)
14. Global Oncology Needle Free Delivery Market By Geography 2014 -2023 ($ Million)
15. Global Other Applications Market By Geography 2014 -2023 ($ Million)
16. Global Needle Free Injector Market By Site of Delivery 2014 -2023 ($ Million)
17. Global Subcutaneous Injectors Market By Geography 2014 -2023 ($ Million)
18. Global Intramuscular Injectors Market By Geography 2014 -2023 ($ Million)
19. Global Intradermal Injectors Market By Geography 2014 -2023 ($ Million)
20. Global Needle Free Injector Market By Type 2014 -2023 ($ Million)
21. Global Liquid-Based Needle-Free Injectors Market By Geography 2014 -2023 ($ Million)
22. Global Projectile/Depot-Based Needle-Free Injectors Market By Geography 2014 -2023 ($ Million)
23. Global Powder-Based Needle Free Injectors Market By Geography 2014 -2023 ($ Million)
24. Global Needle Free Injector Market By Technology 2014 -2023 ($ Million)
25. Global Jet-Based Needle-Free Injectors Market By Geography 2014 -2023 ($ Million)
26. Global Spring-Based Needle-Free Injectors Market By Geography 2014 -2023 ($ Million)
27. Global Laser-Powered Needle-Free Injectors Market By Geography 2014 -2023 ($ Million)
28. Global Vibration-Based Needle-Free Injectors Market By Geography 2014 -2023 ($ Million)
29. Global Needle Free Injection System Market By Product 2014 -2023 ($ Million)
30. Global Fillable Needle-Free Injectors Market By Geography 2014 -2023 ($ Million)
31. Global Prefilled Needle-Free Injectors Market By Geography 2014 -2023 ($ Million)
32. North America Needle Free Injector Market 2014-2023 ($ Million)
33. Europe Needle Free Injector Market 2014-2023 ($ Million)
34. Asia Pacific Needle Free Injector Market 2014-2023 ($ Million)
35. Rest of the World Needle Free Injector Market 2014-2023 ($ Million)

List of Figures
1. Global Hospitals And Clinics Market 2014 -2023 ($ Million)
2. Global Home Care Settings Market 2014 -2023 ($ Million)
3. Global Research Laboratories Market 2014-2022 ($ Millions)
4. Global Pharmaceutical And Biotechnological Companies Market 2014 -2023 ($ Million)
5. Global Other End Users Market 2014 -2023 ($ Million)
6. Global Disposable Needle-Free Injectors Market 2014 -2023 ($ Million)
7. Global Reusable Needle-Free Injectors 2014 -2023 ($ Million)
8. Global Vaccine Needle Free Delivery Market 2014 -2023 ($ Million)
9. Global Insulin Needle Free Delivery Market 2014 -2023 ($ Million)
10. Global Pain Management Needle Free Delivery Market 2014 -2023 ($ Million)
11. Global Oncology Needle Free Delivery Market 2014 -2023 ($ Million)
12. Global Other Applications Market 2014 -2023 ($ Million)
13. Global Subcutaneous Injectors Market 2014 -2023 ($ Million)
14. Global Intramuscular Injectors Market 2014 -2023 ($ Million)
15. Global Liquid-Based Needle-Free Injectors Market 2014 -2023 ($ Million)
16. Global Projectile/Depot-Based Needle-Free Injectors Market 2014 -2023 ($ Million)
17. Global Powder-Based Needle Free Injectors Market 2014 -2023 ($ Million)
18. Global Jet-Based Needle-Free Injectors Market 2014 -2023 ($ Million)
19. Global Spring-Based Needle-Free Injectors Market 2014 -2023 ($ Million)
20. Global Laser-Powered Needle-Free Injectors Market 2014 -2023 ($ Million)
21. Global Vibration-Based Needle-Free Injectors 2014 -2023 ($ Million)
22. Global Fillable Needle-Free Injectors 2014 -2023 ($ Million)
23. Global Prefilled Needle-Free Injectors 2014 -2023 ($ Million)
24. United States (U.S.) Needle Free Injector Market 2014-2023 ($ Million)
25. Canada Needle Free Injector Market 2014-2023 ($ Million)
26. United Kingdom (Uk) Needle Free Injector Market 2014-2023 ($ Million)
27. France Needle Free Injector Market 2014-2023 ($ Million)
28. Germany Needle Free Injector Market 2014-2023 ($ Million)
29. Spain Needle Free Injector Market 2014-2023 ($ Million)
30. Roe Needle Free Injector Market 2014-2023 ($ Million)
31. India Needle Free Injector Market 2014-2023 ($ Million)
32. China Needle Free Injector Market 2014-2023 ($ Million)
33. Japan Needle Free Injector Market 2014-2023 ($ Million)
34. Australia Needle Free Injector Market 2014-2023 ($ Million)
35. Roapac Needle Free Injector Market 2014-2023 ($ Million)
36. Latin America Needle Free Injector Market 2014-2023 ($ Million)
37. Mena Needle Free Injector Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Asia Pharma Pharmaceutical Ltd (Malaysia)
  • Astrazeneca(England)
  • Bioject Medical Technologies (U.S.)
  • Crossject (France)
  • Endo International Plc (U.S.)
  • Envision Pharma Group (England)
  • Injex Pharma Ag (Germany)
  • Inovio Pharmaceuticals Inc. (U.S.)
  • Medical International Technology Inc. (Canada)
  • Merck (U.S.)
  • Mylan (U.S.)
  • National Medical Products Inc. (U.S.)
  • Pharmajet (U.S.)
  • Valeritas Inc. (U.S.)
  • Zogenix (U.S.)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll